Albuterol Sulfate Inhalation Solution
Product Images NDC 67296-1867
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate Inhalation Solution (NDC 67296-1867). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
0.63 mg Cards Carton (0 63 mg Carton Cards)
The text appears to contain information related to a medication called "Albuterol Sulfate Inhalation Solution" that is used for respiratory conditions. It also mentions a specific dosage form called "RITEDOSE." The text seems to include product information such as National Drug Codes (NDC) and some technical details pertaining to the solution.*
0.63 mg Singles Carton (0 63 mg Carton Singles)
1.25 mg Brick Carton (1 25 mg Carton Brick)
1.25 mg Cards Carton (1 25 mg Carton Cards)
This text appears to be a drug label for Albuterol Sulfate Inhalation Solution containing 1.25 mg*/3 mL. The label provides dosage instructions and ingredient information. It instructs the pharmacist to detach part of the label and includes the National Drug Code (NDC) for identification. The recommended dosage may vary, and specific warnings or directions may be included. The text also mentions "RECOIENDEL DOSAGE," "USUAL DOSAGE," and "USUAL DOSAGE 27012." The document seems to have some formatting issues with various characters and spaces.*
1.25 mg Singles Carton (1 25 mg Carton Singles)
Image-01 (Image 01)
Image-02 (Image 02)
This appears to be a table showing the % Change in data over time, with different treatments involving albuterol at various doses and a placebo. The treatments are tracked over a period of time in increments of hours from pre-dose. The table suggests a comparison of the effects of different dosages of albuterol and a placebo on the data being measured or monitored.*
Image-03 (Image 03)
Image-04 (Image 04)
Image-05 (Image 05)
Image-06 (Image 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.